Physician profile
John E Williams
NPI 1588617690
$1,153.94
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.94 · 2021: $296 · 2022: $150 · 2023: $183 · 2024: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.29 | 2022-2024 | Ofev |
| Teleflex LLC | $228.22 | 2022-2023 | Turnpike |
| Inari Medical, INC. | $186.63 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals Lp | $134.84 | 2020-2024 | Breztri |
| Intuitive Surgical, INC. | $123.04 | 2021 | |
| Insmed, INC. | $85.54 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $31.82 | 2020 | |
| Jazz Pharmaceuticals INC. | $23.67 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $22.31 | 2024 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $21.33 | 2024 | |
| Pharmacyclics LLC, An Abbvie Company | $20.43 | 2021 | |
| Karyopharm Therapeutics INC. | $19.10 | 2021 | |
| Gilead Sciences, INC. | $15.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.